CD38 and systemic lupus erythematosus: Our data demonstrate that CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and Transient Receptor Potential Melastatin 2 (TRPM2)-dependent mechanism [17].